<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Grant of Interim Extension of the Term of U.S. Patent No. 5,693,323; Recombinant Humanized Monoclonal Antibody (IgG1, Kappa)-Mepolizumab</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Grant of Interim Extension of the Term of U.S. Patent No. 5,693,323; Recombinant Humanized Monoclonal Antibody (IgG1, Kappa)-Mepolizumab</h1>
    <p class="timestamp">Published: 2014-12-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The United States Patent and Trademark Office has issued an order granting interim extension under 35 U.S.C. 156(d)(5) for a one- year interim extension of the term of U.S. Patent No. 5,693,323.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Commerce Department, Patent and Trademark Office</p>
    <p><strong>Document Number:</strong> 2014-28966</p>
    <p><strong>Publication Date:</strong> 2014-12-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/12/10/2014-28966/grant-of-interim-extension-of-the-term-of-us-patent-no-5693323-recombinant-humanized-monoclonal">https://www.federalregister.gov/documents/2014/12/10/2014-28966/grant-of-interim-extension-of-the-term-of-us-patent-no-5693323-recombinant-humanized-monoclonal</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-28966</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
